8.
Rh-negative women of childbearing age without malignant disease should not
receive platelet concentrates from ______ donors because of the effect of possible
anti-Rh on future pregnancies.
a. Rh-immune donors.
b. Rh-positive donors.
c.
Rh-negative donors.
d. ABO-incompatible donors.
9.
What relatively high risk do commercial concentrates of Factor IX carry?
a. Hemophilia.
b. Hemolytic reactions.
c.
Disease transmission.
d. Intravascular coagulation.
10.
What is one advantage of commercial plasma substitutes (plasma protein fraction
of 5 percent albumin in saline)?
a. No risk of hepatitis.
b. Usefulness in severe anemias.
c.
The presence of most clotting factors.
d. Usefulness in congestive heart failure.
11.
"Syringe" transfusions are recommended for premature and newborn infants.
a. True.
b. False.
MD0846
3-48